Rethinking Drug Interactions: A Focal Shift in AI Prediction
A new approach in graph neural networks significantly boosts drug interaction predictions. Focusing on tougher cases, the ClinicalFocal loss shows striking improvements over traditional methods.
Read the full articleYou might also wanna read
AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
Featured content
drugtargetreview.com·5mo ago
Deep-learning platform GPS enables de novo drug discovery by predicting transcriptomic perturbations from chemical structures
Bulk and single-cell transcriptomics are widely used to characterize diseases and cellular states but remain underexplored for de novo drug
DeepCYP: A deep learning web server for predicting CYP450 drug metabolism pathways
Abstract. CYP450 (cytochrome P450)-mediated drug metabolism is a critical determinant of pharmacokinetics and clinical safety, making compre
doi.org·18d ago
Network-driven discovery of repurposable drugs targeting hallmarks of aging
Network-driven discovery of repurposable drugs targeting hallmarks of aging
MCP and Pharma: How AI Agents Connect to Drug Discovery, Clinical Trials, Genomics, Chemical Databases, Protein Structure, FDA Regulatory Data, and Life Sciences Platforms
A comprehensive guide to MCP integrations for pharmaceuticals, biotechnology, and life sciences — covering drug discovery tools (RDKit, mole
Facilitating structure-based drug discovery with an artificial intelligence-driven virtual screening platform
Facilitating structure-based drug discovery with an artificial intelligence-driven virtual screening platform ->Nature
Comments
Sign in to join the conversation.
No comments yet. Be the first.